Harrow (HROW) EBITDA (2010 - 2026)
Harrow (HROW) recorded quarterly EBITDA of -$22.1 million in Q1 2026, down 241.62% quarter-over-quarter from $15.6 million in Q4 2025, and down 96.58% on a YoY basis from -$645.8 million in Q1 2025.
Harrow (HROW) EBITDA (2010 - 2026) Analysis & Trends
Harrow's EBITDA history runs 17 years deep, the most recent figure standing at -$22.1 million for Q1 2026.
- In Q1 2026, EBITDA fell 96.58% year-over-year to -$22.1 million; the TTM figure through Mar 2026 stood at $19.7 million (up 335.3% YoY), while the FY2025 annual figure was $30.5 million, up 245.9% from the prior year.
- EBITDA was -$22.1 million for Q1 2026 at Harrow, down from $15.6 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $15.6 million in Q4 2025 to a low of -$22.1 million in Q1 2026.
- Historically, EBITDA has averaged $1.2 million across 5 years, with a median of $1.5 million in 2024.
- The sharpest annual moves came in 2023 and 2024: EBITDA surged 1955.32% in 2023, then slumped 672.56% in 2024.
- A 5-year view of EBITDA shows it stood at -$1.8 million in 2022, then sank by 174.18% to -$4.9 million in 2023, then surged by 364.59% to $12.9 million in 2024, then increased by 20.87% to $15.6 million in 2025, then tumbled by 241.62% to -$22.1 million in 2026.
- The last three EBITDA figures came in at -$22.1 million (Q1 2026), $15.6 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -98.81 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | -22.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.08 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Sep 30, 2025 | 14.75 Mn |
| Jun 30, 2025 | 11.41 Mn |
| Mar 31, 2025 | -11.23 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | -6.93 Mn |
| Dec 31, 2023 | -4.88 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | -1.78 Mn |
| Sep 30, 2022 | -94,000.00 |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | -1.76 Mn |
| Sep 30, 2021 | -3.72 Mn |
| Jun 30, 2021 | 4.17 Mn |